Lucia Bailon
Cerdanyola Del Valles, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Gender-Specific Determinants of Frailty in Aging People with HIV: Evidence for a Multidimensional Vulnerability Phenotype in Women.
Journal: Viruses
Published: June 09, 2026
Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._.
Journal: Communications medicine
Published: July 18, 2025
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.
Journal: Open forum infectious diseases
Published: July 03, 2025
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial).
Journal: The Journal of infection
Published: May 19, 2025
Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)-a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol.
Journal: BMJ open
Published: April 11, 2025
Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy.
Journal: PLoS pathogens
Published: March 03, 2025
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.
Journal: Nature communications
Published: October 31, 2024
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.
Journal: The Journal of clinical investigation
Published: June 20, 2024
Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood.
Journal: The Journal of infectious diseases
Published: May 23, 2024
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial.
Journal: Vaccine
Published: April 23, 2024
Early virological failure with cabotegravir/rilpivirine.
Journal: The Journal of antimicrobial chemotherapy
Published: February 22, 2024
Last Updated: 09/26/2026